Saturday, August 2, 2008
Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
Abstract Purpose To evaluate the efficacy and safety of gemcitabine in combination with carboplatin at standard rate or fixed dose rate infusion in patients with advanced non-small-cell lung cancer (NSCLC).
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment